Mendelian Randomization Study of Lipid Metabolites Reveals Causal Associations with Heel Bone Mineral Density
暂无分享,去创建一个
Z. Li | Hengxing Zhou | Chi Zhang | Shiqing Feng | Enling Qi | Mingxin Wu | Yufei Du | Qingyang Li | Wendong Ruan | Hengxing Zhou
[1] K. Wellen,et al. Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis , 2023, Science advances.
[2] Shuhong Chen,et al. Metabolome-Wide Mendelian Randomization Assessing the Causal Relationship Between Blood Metabolites and Bone Mineral Density , 2023, Calcified Tissue International.
[3] H. Pan,et al. Causal effect of polyunsaturated fatty acids on bone mineral density and fracture , 2022, Frontiers in Nutrition.
[4] A. A. Abdel Rahman,et al. Lipidomics Profiling of Patients with Low Bone Mineral Density (LBMD) , 2022, International journal of molecular sciences.
[5] O. Shen,et al. Association Between Human Blood Metabolome and the Risk of Psychiatric Disorders. , 2022, Schizophrenia bulletin.
[6] S. Capuani,et al. Behavior during aging of bone-marrow fatty-acids profile in women's calcaneus to search for early potential osteoporotic biomarkers: A 1H-MR spectroscopy study. , 2022, Bone.
[7] Zeng-hui Zhao,et al. Polyunsaturated Fatty Acids Level and Bone Mineral Density: A Two-Sample Mendelian Randomization Study , 2022, Frontiers in Endocrinology.
[8] J. Mano,et al. Endo- and Exometabolome Crosstalk in Mesenchymal Stem Cells Undergoing Osteogenic Differentiation , 2022, Cells.
[9] Xiaoting Luo,et al. UPLC/Q-TOF-MS-based Metabolomics Study of the Antiosteoporosis Effects of Vaccarin in Ovariectomized Mice , 2022, Planta Medica.
[10] Li-juan Wang,et al. Association between lipid biomarkers and osteoporosis: a cross-sectional study , 2020, BMC Musculoskeletal Disorders.
[11] N. Sheehan,et al. The use of two-sample methods for Mendelian randomization analyses on single large datasets , 2020, bioRxiv.
[12] Yue Zhu,et al. Mapping theme trends and recognizing hot spots in postmenopausal osteoporosis research: a bibliometric analysis , 2019, PeerJ.
[13] Dhani Raj Chhetri,et al. Myo-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases , 2019, Front. Pharmacol..
[14] M. Fornage,et al. A prospective study of serum metabolites and risk of ischemic stroke , 2019, Neurology.
[15] R. Ventura,et al. Sulfate metabolites improve retrospectivity after oral testosterone administration. , 2018, Drug testing and analysis.
[16] Julian M. W. Quinn,et al. An atlas of genetic influences on osteoporosis in humans and mice , 2018, Nature Genetics.
[17] J. Ärnlöv,et al. A Mendelian randomization study of the effects of blood lipids on breast cancer risk , 2018, Nature Communications.
[18] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[19] F. Müller,et al. Biomarkers for In Vivo Assessment of Transporter Function , 2018, Pharmacological Reviews.
[20] T. Spector,et al. Metabolomic Pathways to Osteoporosis in Middle‐Aged Women: A Genome‐Metabolome‐Wide Mendelian Randomization Study , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] M. Thevis,et al. Epiandrosterone sulfate prolongs the detectability of testosterone, 4-androstenedione, and dihydrotestosterone misuse by means of carbon isotope ratio mass spectrometry. , 2017, Drug testing and analysis.
[22] S. Khosla,et al. Osteoporosis treatment: recent developments and ongoing challenges. , 2017, The lancet. Diabetes & endocrinology.
[23] Michael Jones,et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer , 2017, Nature Genetics.
[24] S. Thompson,et al. Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.
[25] Y. Miki,et al. Phosphatidylethanolamine dynamics are required for osteoclast fusion , 2017, Scientific Reports.
[26] Fernando Pires Hartwig,et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.
[27] H. Schuppe,et al. Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: Evidence from steroid sulfatase deficiency , 2016, Molecular and Cellular Endocrinology.
[28] N. Sheehan,et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic , 2016, International journal of epidemiology.
[29] A. Garber,et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[30] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[31] M. Bozzali,et al. Bone Marrow Lipid Profiles from Peripheral Skeleton as Potential Biomarkers for Osteoporosis: A 1H-MR Spectroscopy Study. , 2016, Academic radiology.
[32] Stephen Burgess,et al. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.
[33] David M. Evans,et al. Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. , 2015, Annual review of genomics and human genetics.
[34] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[35] N. Timpson,et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors , 2015, European Journal of Epidemiology.
[36] I. Mohamed,et al. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality , 2014, Therapeutics and clinical risk management.
[37] R. Willumeit,et al. Phosphatidylethanolamine biomimetic coating increases mesenchymal stem cell osteoblastogenesis , 2014, Journal of Materials Science: Materials in Medicine.
[38] John P. Overington,et al. An atlas of genetic influences on human blood metabolites , 2014, Nature Genetics.
[39] C. Gieger,et al. Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism , 2014, European Journal of Epidemiology.
[40] Anita Taylor,et al. The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review , 2012, JBI library of systematic reviews.
[41] E. Lewiecki,et al. Osteoporosis , 2011, Annals of Internal Medicine.
[42] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[43] D. Miao,et al. Sodium/myo‐inositol cotransporter 1 and myo‐inositol are essential for osteogenesis and bone formation , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[44] C. Hoppel,et al. Mitochondria in the elderly: Is acetylcarnitine a rejuvenator? , 2009, Advanced drug delivery reviews.
[45] E. Elm,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[46] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[47] M. Haddaway,et al. Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites. , 2006, Age and ageing.
[48] G. Mundy. Nutritional modulators of bone remodeling during aging. , 2006, The American journal of clinical nutrition.
[49] S. Chung,et al. Sodium/myo‐inositol cotransporter‐1 is essential for the development and function of the peripheral nerves , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] D. Black,et al. Clinical Practice. Postmenopausal Osteoporosis. , 2005, The New England journal of medicine.
[51] R. E. Small,et al. Uses and limitations of bone mineral density measurements in the management of osteoporosis. , 2005, MedGenMed : Medscape general medicine.
[52] Robert Luben,et al. Prediction of total and hip fracture risk in men and women by quantitative ultrasound of the calcaneus: EPIC-Norfolk prospective population study , 2004, The Lancet.
[53] C C Glüer,et al. Comparisons of Noninvasive Bone Mineral Measurements in Assessing Age‐Related Loss, Fracture Discrimination, and Diagnostic Classification , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[54] C. Christiansen. Osteoporosis: diagnosis and management today and tomorrow. , 1995, Bone.
[55] M. Ito,et al. Calcaneus as a site for assessment of bone mineral density: evaluation in cadavers and healthy volunteers. , 1993, AJR. American journal of roentgenology.
[56] G. Berry,et al. Kinetic evidence for compartmentalization of myo-inositol in hepatocytes. , 1993, Metabolism: clinical and experimental.
[57] Claus Christiansen,et al. Diagnosis of Osteoporosis , 1992, Southern medical journal.
[58] G. Nelsestuen,et al. Importance of phosphatidylethanolamine for association of protein kinase C and other cytoplasmic proteins with membranes. , 1992, Biochemistry.
[59] J. Bremer,et al. Propionylcarnitine. Physiological variations in vivo. , 1968, Biochimica et biophysica acta.
[60] A. Khera,et al. Mendelian Randomization. , 2017, JAMA.
[61] S. Claypool,et al. Phosphatidylethanolamine Metabolism in Health and Disease. , 2016, International review of cell and molecular biology.
[62] L. Tosi,et al. Fragility fractures: the fall and decline of bone health. Commentary on "Interventions to improve osteoporosis treatment following hip fracture" by Gardner et Al. , 2005, The Journal of bone and joint surgery. American volume.
[63] P. Orozco. Atherogenic lipid profile and elevated lipoprotein (a) are associated with lower bone mineral density in early postmenopausal overweight women , 2004, European Journal of Epidemiology.
[64] M. Giger,et al. Normalized BMD as a predictor of bone strength. , 2000, Academic radiology.